These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 7353578

  • 1. Transitional cell carcinoma of the bladder. Differences between primary tumour and following relapses.
    Pizza G, Viza D, Fini M, Cuzzocrea D, Menniti D, Corrado F.
    Eur Urol; 1980; 6(1):45-7. PubMed ID: 7353578
    [Abstract] [Full Text] [Related]

  • 2. Cell-mediated tumour immunity in patients with transitional cell carcinoma of the urinary bladder.
    Bubeník J.
    Int Urol Nephrol; 1975; 7(4):297-302. PubMed ID: 1107249
    [Abstract] [Full Text] [Related]

  • 3. A new tumour marker tested in 98 patients with bladder carcinoma.
    Metcalfe SM, Jamieson NV.
    Ann R Coll Surg Engl; 1984 Nov; 66(6):399-401. PubMed ID: 6508158
    [Abstract] [Full Text] [Related]

  • 4. Leukocyte migration inhibition assay in patients with bladder cancer.
    Schellhammer PF, Wright GL, Rosato FE, Faulconer RJ.
    J Urol; 1979 Dec; 122(6):746-9. PubMed ID: 513216
    [Abstract] [Full Text] [Related]

  • 5. CA-50 as tumour marker in transitional bladder carcinoma.
    Tizzani A, Casetta G, Piana P, Piantino P.
    Br J Urol; 1989 Jun; 63(6):616-8. PubMed ID: 2752254
    [Abstract] [Full Text] [Related]

  • 6. Immunologic reduction of bladder cancer recurrence rate.
    Olsson CA, Chute R, Rao CN.
    J Urol; 1974 Feb; 111(2):173-6. PubMed ID: 4810758
    [No Abstract] [Full Text] [Related]

  • 7. Expression of Leu-M1 antigens in carcinoma of the urinary bladder.
    Hoshi S, Orikasa S, Numata I, Nose M.
    J Urol; 1986 May; 135(5):1075-7. PubMed ID: 3083124
    [Abstract] [Full Text] [Related]

  • 8. Expression of CD15 antigen in urinary bladder transitional cell carcinoma.
    Parham DM, Morton K, Coghill G, Robertson AJ, Kerr MA.
    J Clin Pathol; 1990 Jul; 43(7):541-3. PubMed ID: 1974266
    [Abstract] [Full Text] [Related]

  • 9. [Immunological detection of an antigen associated with human bladder carcinoma cell lines].
    Tsukahara K.
    Nihon Hinyokika Gakkai Zasshi; 1982 Oct; 73(10):1249-58. PubMed ID: 7166918
    [No Abstract] [Full Text] [Related]

  • 10. In vitro production of a transfer factor specific for transitional-cell carcinoma of the bladder.
    Pizza G, Viza D, Boucheix C, Corrado F.
    Br J Cancer; 1976 Jun; 33(6):606-11. PubMed ID: 938610
    [Abstract] [Full Text] [Related]

  • 11. Use of monoclonal antibody E48 in diagnosing transitional cell carcinoma of urinary bladder.
    Torenbeek R, Blomjous CE, Quak JJ, Ybema S, Meijer CJ.
    J Clin Pathol; 1992 Apr; 45(4):303-7. PubMed ID: 1374431
    [Abstract] [Full Text] [Related]

  • 12. Leukocyte migration inhibition in vitro in bladder carcinoma.
    Lavergne JA, Lamm DL, Radwin HM, Harrington JT.
    Cancer Res; 1979 Jun; 39(6 Pt 1):1985-8. PubMed ID: 445398
    [Abstract] [Full Text] [Related]

  • 13. Monoclonal antibodies to detect A, B and H blood group isoantigens in superficial transitional cell carcinoma of the bladder: a means of predicting invasive recurrences.
    Stephenson TJ, Williams JL, Gelsthorpe K.
    Br J Urol; 1985 Apr; 57(2):148-53. PubMed ID: 3886066
    [Abstract] [Full Text] [Related]

  • 14. Antigen(s) on human transitional cell carcinoma detected by a xenogeneic antiserum.
    Bloom ET.
    Urol Res; 1977 Apr; 5(3):141-8. PubMed ID: 919114
    [Abstract] [Full Text] [Related]

  • 15. Transitional cell carcinoma: circulating tumor antigen correlated with presence/absence of tumor (leukocyte migration assay).
    Bowen JG.
    Natl Cancer Inst Monogr; 1978 Dec; (49):245-7. PubMed ID: 748778
    [Abstract] [Full Text] [Related]

  • 16. [HL-A antigenicity in bladder tumors].
    Jakse G, Hofstädter F.
    Helv Chir Acta; 1978 Jul; 45(3):313-6. PubMed ID: 701068
    [Abstract] [Full Text] [Related]

  • 17. Expression of squamous cell carcinoma-associated antigen in grade 3 pT1 transitional cell carcinoma of the bladder and prediction of its progression and intravesical recurrence.
    Yamazaki K, Kumamoto Y, Tsukamoto T.
    Cancer; 1993 Dec 15; 72(12):3676-84. PubMed ID: 7902777
    [Abstract] [Full Text] [Related]

  • 18. Nuclear volume and expression of T-antigen, sialosyl-Tn-antigen, and Tn-antigen in carcinoma of the human bladder. Relation to tumor recurrence and progression.
    Langkilde NC, Wolf H, Clausen H, Kjeldsen T, Orntoft TF.
    Cancer; 1992 Jan 01; 69(1):219-27. PubMed ID: 1727666
    [Abstract] [Full Text] [Related]

  • 19. Detection of antigenic differences and similarities between human transitional cell carcinoma cell lines using rabbit antisera.
    Bloom ET, Brown DE.
    Urol Res; 1980 Jan 01; 8(1):5-13. PubMed ID: 6154368
    [No Abstract] [Full Text] [Related]

  • 20. [Immunohistochemical demonstration of tumor-associated antigens in urinary bladder carcinomas using mono- and polyclonal antisera].
    Friedmann W, Steffens J, Lobeck H.
    Onkologie; 1985 Apr 01; 8(2):105-10. PubMed ID: 2582324
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.